| Stage | CAH | % of rev | MDLN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $67.5B | 100.00% | $7.9B | 100.00% | CAH ×8.59 |
| Gross profit | $2.6B | 3.85% | $1.9B | 24.50% | MDLN +20.7pp |
| Operating income | $753M | 1.12% | $500M | 6.36% | MDLN +5.2pp |
| Pre-tax income | $688M | 1.02% | $386M | 4.91% | MDLN +3.9pp |
| Net income | $556M | 0.82% | $318M | 4.05% | MDLN +3.2pp |
| Stage | CAH | MDLN | Gap · A − B |
|---|---|---|---|
| Revenue | $67.5B100.00% | $7.9B100.00% | CAH ×8.59 |
| Gross profit | 3.85%$2.6B | 24.50%$1.9B | MDLN +20.7pp |
| Operating income | 1.12%$753M | 6.36%$500M | MDLN +5.2pp |
| Pre-tax income | 1.02%$688M | 4.91%$386M | MDLN +3.9pp |
| Net income |
| 0.82%$556M |
| 4.05%$318M |
| MDLN +3.2pp |
No shared counterparties.